• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Obstetrics

Low-dose gonadotropin ovulation induction superior to clomiphene

byMaren ShapiroandLeah Hawkins Bressler, MD, MPH
March 21, 2015
in Obstetrics
Reading Time: 3 mins read
0
Share on FacebookShare on Twitter

1. Among infertile couples undergoing intrauterine insemination (IUI), those randomized to ovulation induction with low-dose gonadotropins achieved a higher live birth rate than women on clomiphene.

2. Low-dose gonadotropin stimulation was associated with similar incidence of multiple pregnancy and multiple live births compared to clomiphene.

Evidence Rating Level: 1 (Excellent)      

Study Rundown: Infertility, the failure to conceive after one year of regular, unprotected intercourse, impacts roughly 10 percent of couples. The first line treatment for many couples is intrauterine insemination (IUI), which involves introducing sperm directly into the uterus. Pregnancy rates following can be significantly improved with timed ovulation stimulation, termed ovulation induction. Clomiphene citrate, a selective estrogen receptor modulator or SERM, is often used for ovarian induction due to inexpense, ease of use and lower rate of multiples compared with gonadotropin stimulation. Clomiphene works by blocking estrogen receptors in the brain and preventing the negative feedback of estrogen on the hypothalamus, thereby increasing gonadotrophin production and stimulating ovarian follicle growth. The menopausal gonadotropins luteinizing hormone (LH) and follicle-stimulating hormone (FSH), on the other hand, act directly on ovarian LH and FSH receptors to induce a hypergonadotropic state thus stimulating follicle growth. While some randomized trials have identified improved pregnancy rates with gonadotropin stimulation, others failed to identify this association. Additionally, gonadotropin-IUI is associated with an increased risk of multiple pregnancy, including higher order multiple gestations. In this multi-center, randomized controlled trial, researchers assessed whether ovarian stimulation with low-dose gonadotropin might achieve improved efficacy without increased risk of multiple gestations compared to clomiphene induction.

Compared to clomiphene, low-dose gonadotropin was associated with more clinical pregnancies and a higher live birth rate without an increased incidence of multiples among couples with infertility undergoing IUI. One potential limitation is that couples were allowed to reenter the study for multiple cycles of IUI, which could bias results against couples who achieve early success; however, this was tempered by repeat randomization of couples for each cycle. Given the increased cost and daily injection required with the gonadotropin induction, inclusion of patient satisfaction and healthcare costs in future studies would provide additionally useful clinical information.

Click to read the study in Human Reproduction

RELATED REPORTS

Differential optimal follicle sizes for ovulatory dysfunction and unexplained infertility

Fresh embryo transfer may yield higher rates of success for women with low prognosis for in vitro fertilization

Poor cardiovascular health is a risk factor for female infertility

Relevant Reading: Effectiveness and treatment for unexplained infertility

In-Depth [randomized controlled trial]: A total of 330 women scheduled to undergo a total of 657 cycles of intrauterine insemination (IUI) were randomized to receive pre-insemination ovarian stimulation with either subcutaneous low-dose human menopausal gonadotropins (n=334) or clomiphene (n=323). Indications for IUI were mild male subfertility, unexplained infertility or minimal-mild endometriosis. The major outcome was clinical pregnancy.

Compared with ovarian stimulation with clomiphene, gonadotropin stimulation resulted in a higher clinical pregnancy rate (14.4% vs. 9.0%, 95%CI 1.1-2.4) and more live births (13.8% vs. 8.7%, 95%CI 1.0-2.4). Rates of multiple pregnancy and multiple births were comparable between groups (p>0.99).

Image: CC/WikiCommons ScienceGenetics

©2014 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. No article should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2 Minute Medicine, Inc.

Tags: Clomiphenegonadotropininfertility
Previous Post

Mogen circumcision associated with shorter operation time and less pain

Next Post

Pimecrolimus effective first-line treatment for atopic dermatitis

RelatedReports

Paternal factors associated with short interpregnancy interval
Chronic Disease

Differential optimal follicle sizes for ovulatory dysfunction and unexplained infertility

March 10, 2025
Paternal factors associated with short interpregnancy interval
Chronic Disease

Fresh embryo transfer may yield higher rates of success for women with low prognosis for in vitro fertilization

February 3, 2025
American Academy of Pediatrics recommends standards for adverse event disclosures
Cardiology

Poor cardiovascular health is a risk factor for female infertility

July 11, 2024
Letrozole (Femara) boosts fertility of women with Polycystic Ovarian Syndrome
Chronic Disease

Bariatric surgery may improve rates for spontaneous ovulation in patients with polycystic ovarian syndrome and obesity

June 12, 2024
Next Post
Pimecrolimus effective first-line treatment for atopic dermatitis

Pimecrolimus effective first-line treatment for atopic dermatitis

Collaborative care may improve outcomes in childhood ADHD

Collaborative care may improve outcomes in childhood ADHD

Incidental findings common with breast imaging, often benign

2 Minute Medicine Rewind March 16 – March 22, 2015

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • 2 Minute Medicine Rewind July 7, 2025
  • Fecal calprotectin is a useful marker for defining small bowel endoscopic remission in Crohn’s disease
  • Body mass index-specific waist circumference thresholds may improve mortality risk stratification in women
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.